CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 56 enrolled
Drug / intervention
Fluticasone propionate 0.05% lotiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00546000
NCT00546000Phase 4Completed
CompareCT.gov

A Multi-Center, Open-Label Study to Evaluate the Effect of ALTANA Inc's Cutivate (Fluticasone Propionate) Lotion 0.05% on the Hypothalmic Pituitary Adrenal (HPA) Axis in the Treatment of Atopic Dermatitis in a Pediatric Population

Fougera Pharmaceuticals Inc.·interventional·Posted Oct 18, 2007·Updated Jul 24, 2014

In Brief

A Phase 4 clinical trial evaluating Fluticasone propionate 0.05% lotion for Atopic Dermatitis. Completed, enrolled 56 participants across 10 sites.

Detailed Summary

A multi-center, open-label, Phase IV, unblinded study using Cutivate (fluticasone propionate, 0.05%)lotion and it's possible effects on the HPA axis of infants diagnosed with atopic dermatitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 18, 2007
Enrollment StartJul 1, 2007
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.7 years ago

Interventions

Fluticasone propionate 0.05% lotiondrug

Daily applications